There are reports that show that anti-PD-1 antibodies are affected by Fc-FcγR interactions and other groups have evaluated detrimental effects in the functional activity of anti-PD-1 antibodies when engaging Fc receptors on macrophages specifically in the tumor microenvironment. The gene discussed is FCGR2A; the disease is neoplasm.